ATM-inhibitor AZD1390 is a radiosensitizer for breast cancer CNS metastasis. Tew BY, Kalfa AJ, Yang Z, Hurth KM, et al. Clin Cancer Res 2023 Aug 16:CCR-23-0290. doi: 10.1158/1078-0432.CCR-23-0290.

Read + Share

Amedeo Smart

Independent Medical Education

Tew BY, Kalfa AJ, Yang Z, Hurth KM, et al. ATM-inhibitor AZD1390 is a radiosensitizer for breast cancer CNS metastasis. Clin Cancer Res 2023 Aug 16:CCR-23-0290. doi: 10.1158/1078-0432.CCR-23-0290.
PMID: 37585496